Taiwan Bio Therapeutics
Investors
  1. Home
  2. Investors
  3. Corporate Governance
  4. Committees
  5. Compensation Committee
Corporate Governance
Board of Directors Committees Corporate Governance Officer Major Internal Policies
Financials
Monthly Revenue Financial Reports
Shareholder Services
Major Shareholders Meeting Information Stakeholder Contact Prospectuses Material Information Dividend and Stock
Investor Conference
Interested Parties
Audit Committee Compensation Committee
Committee members

Title Name
Chairperson Amy Chen
Member C. H Liu
Member Eric Wu


The term of the current committee members: 9 June 2024 to 18 June 2027.
The Operation of the Compensation Committee
The Committee shall convene at least twice a year. Its members, in a professional and objective capacity, are responsible for evaluating the Company's compensation policies and systems for directors and managerial officers, and providing recommendations to the Board of Directors for decision-making reference.

For further details regarding the Committee's operations, please refer to the Compensation Committee Charter.
Audit Committee Resolution
Date Resolution
May 12
  • Approval of the list of grantees and the number of shares granted under the 2023 employee stock option plan.
  • Approval of the compensation plan for the Company's managerial officers.
Mar. 12
  • Approval of the distribution of year-end bonuses for the Company’s managerial officers for 2024.
  • Approval of the compensation plan for the Company’s managerial officers.
  • Approval of the compensation plan for the newly appointed managerial officers.